Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes

IMPORTANCE: Pretreatment of patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) with P2Y12 receptor antagonists is a common practice despite the lack of definite evidence for its benefit. OBJECTIVE: To investigate the association of P2Y12 receptor antagonist pretreatment vs no...

Descripción completa

Detalles Bibliográficos
Autores principales: Dworeck, Christian, Redfors, Björn, Angerås, Oskar, Haraldsson, Inger, Odenstedt, Jacob, Ioanes, Dan, Petursson, Petur, Völz, Sebastian, Persson, Jonas, Koul, Sasha, Venetsanos, Dimitrios, Ulvenstam, Anders, Hofmann, Robin, Jensen, Jens, Albertsson, Per, Råmunddal, Truls, Jeppsson, Anders, Erlinge, David, Omerovic, Elmir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530628/
https://www.ncbi.nlm.nih.gov/pubmed/33001202
http://dx.doi.org/10.1001/jamanetworkopen.2020.18735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530628/
https://www.ncbi.nlm.nih.gov/pubmed/33001202
http://dx.doi.org/10.1001/jamanetworkopen.2020.18735

Ejemplares similares